Target intelligence / Profile preview

Wheat gluten protein (Gluten)

Target
Gluten
Molecular classification
Storage protein, Other
01

Overview

Wheat gluten proteins, primarily composed of gliadins and glutenins, are the major storage proteins found in wheat. These proteins are characterized by a high content of proline and glutamine residues, which renders them highly resistant to complete digestion by human gastrointestinal proteases (https://pubmed.ncbi.nlm.nih.gov/19515230/). In individuals with Celiac disease, the resulting long peptide fragments are deamidated by tissue transglutaminase and presented by HLA-DQ2 or HLA-DQ8 molecules, triggering an inflammatory T-cell response that leads to intestinal villous atrophy (https://www.niddk.nih.gov/health-information/digestive-diseases/celiac-disease). From a therapeutic perspective, wheat gluten proteins serve as exogenous targets for oral enzyme replacement therapies, such as latiglutenase, which aim to degrade these immunogenic peptides into smaller, non-toxic fragments before they reach the small intestine (https://clinicaltrials.gov/ct2/show/NCT01917630). Other strategies involve using polymers to sequester gluten or tight-junction regulators to prevent its translocation across the epithelial barrier. While not an endogenous human receptor or enzyme, gluten is the primary driver of several autoimmune and allergic pathologies, making its neutralization or degradation a significant focus in gastroenterological drug development.

Other names
GlutenGliadinGluteninTriticum aestivum storage proteinsProlamins
02

Mechanism of action

Enzymatic degradation of immunogenic peptides (proteolysis), reduction of intestinal permeability to prevent protein translocation, and sequestration of antigenic fragments.

03

Biological functions

Seed storageNutrient sourceImmunogenAllergen
04

Disease associations

Celiac diseaseWheat allergyNon-celiac gluten sensitivityDermatitis herpetiformisGluten ataxia
05

Safety considerations

Incomplete degradation of toxic epitopesPotential for cross-reactivity in allergic patientsReliance on enzymes potentially leading to reduced adherence to a gluten-free dietEnzyme stability in the acidic gastric environment
06

Interacting drugs

Latiglutenase

3 more in the full profile.

07

Biomarkers

Anti-tissue transglutaminase (tTG) antibodiesAnti-deamidated gliadin peptide (DGP) antibodiesAnti-endomysial antibodies (EMA)HLA-DQ2/DQ8 genotypeGluten-immunogenic peptides (GIP) in stool/urine

Beyond the preview

Go deeper on Wheat gluten protein (Gluten).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wheat gluten protein (Gluten).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call